Skip to Main Content
Skip Nav Destination

Dr. Dagogo-Jack has served as a principal investigator or co-investigator for clinical trial contracts between the University of Tennessee and AstraZeneca, Novo Nordisk, and Boehringer-Ingelheim; has served as a consultant and advisory board member for AstraZeneca, Bayer, Boehringer-Ingelheim, Janssen Pharmaceuticals, Merck, Novo Nordisk, and Sanofi; and holds equity interests in Jana Care, Inc., and Aerami Therapeutics. He has also served as an expert for Sidley Austin, Adam and Reese, and Wheeler Trigg O’Donnell law firms on litigation related to diabetes and hormonal disorders.

Data & Figures

Contents

References

Close Modal

or Create an Account

Close Modal
Close Modal